Skip to content

Clinical trials

Amyloidosis trials in Germany

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Amyloidosis Country / region: Germany Clear all

40 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20071
20083
20091
20101
20121
20134
20142
20151
20162
20171
20192
20206
20214
20222
20231
20243
20253
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed18
Recruiting11
Active, not recruiting6
Terminated2
Unknown status2
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Alnylam Pharmaceuticals8
Pfizer6
Ionis Pharmaceuticals, Inc.5
Janssen Research & Development, LLC2
Neurimmune AG2
Prothena Biosciences Ltd.2
Akcea Therapeutics1
Alexion Pharmaceuticals, Inc.1
AstraZeneca1
C.T. Development America, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Amyloidosis40
Amyloid Neuropathies, Familial15
Cardiomyopathies9
Polyneuropathies9
Alzheimer Disease6
Amyloidosis, Familial6
Amyloid Neuropathies3
Aortic Valve Stenosis3
Immunoglobulin Light-chain Amyloidosis3
Cardiomyopathy, Dilated2

Trials

Showing 51 to 40 of 40. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.